Stock Research for OSIR

Current Price


Latest Update: 2018-03-22 15:55:00

$ 8.9500
$ 8.9500
$ 8.9500

Featured Broker: TradeStation

Get the due diligence for another stock.


OSIR Stock Chart & Research Data

The OSIR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OSIR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


OSIR Due diligence Resources & Stock Charts

The OSIR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OSIR Detailed Price Forecast - CNN Money CNN View OSIR Detailed Summary - Google Finance
Yahoo View OSIR Detailed Summary - Yahoo! Finance Zacks View OSIR Stock Research & Analysis -

Stock Analysis

TradeIdeas View OSIR Trends & Analysis - Trade-Ideas Barrons View OSIR Major Holders - Barrons
NASDAQ View OSIR Call Transcripts - NASDAQ Seeking View OSIR Breaking News & Analysis - Seeking Alpha
Spotlight View OSIR Annual Report - OTC Report View OSIR OTC Short Report -
TradeKing View OSIR Fundamentals - TradeKing Charts View OSIR SEC Filings - Bar Chart
WSJ View Historical Prices for OSIR - The WSJ Morningstar View Performance/Total Return for OSIR - Morningstar
MarketWatch View the Analyst Estimates for OSIR - MarketWatch CNBC View the Earnings History for OSIR - CNBC
StockMarketWatch View the OSIR Earnings - StockMarketWatch MacroAxis View OSIR Buy or Sell Recommendations - MacroAxis
Bullish View the OSIR Bullish Patterns - American Bulls Short Pains View OSIR Short Pain Metrics -

Social Media Mentions

StockTwits View OSIR Stock Mentions - StockTwits PennyStocks View OSIR Stock Mentions - PennyStockTweets
Twitter View OSIR Stock Mentions - Twitter Invest Hub View OSIR Investment Forum News - Investor Hub
Yahoo View OSIR Stock Mentions - Yahoo! Message Board Seeking Alpha View OSIR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for OSIR - Insider Cow View Insider Transactions for OSIR - Insider Cow
CNBC View OSIR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OSIR - OTC Markets
Yahoo View Insider Transactions for OSIR - Yahoo! Finance NASDAQ View Institutional Holdings for OSIR - NASDAQ

Stock Charts

FinViz View OSIR Stock Insight & Charts - StockCharts View OSIR Investment Charts -
BarChart View OSIR Stock Overview & Charts - BarChart Trading View View OSIR User Generated Charts - Trading View

Latest Financial News for OSIR

Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO
Posted on Tuesday February 06, 2018

COLUMBIA, Md., Feb. 06, 2018-- Osiris Therapeutics, Inc. is pleased to announce that its Board of Directors, at a Board Meeting on February 6 th, 2018, appointed Mr. Willi Miesch as a Director, upon recommendation ...

Update in Lawsuit for Investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) Shares Announced by Shareholders Foundation
Posted on Tuesday November 28, 2017

SAN DIEGO, CA / ACCESSWIRE / November 28, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors who purchased NASDAQ: OSIR shares against Osiris Therapeutics, ...

Former Osiris Therapeutics executive pleads guilty to false statements
Posted on Thursday November 02, 2017

A former chief financial officer of biotechnology company Osiris Therapeutics on Thursday pleaded guilty to making false statements to auditors to inflate the company's reported revenue. Philip Jacoby, 65, entered his plea before U.S. District Judge Denise Cote in in Manhattan, while Osiris separately agreed to pay $1.5 million to settle a related civil lawsuit by the U.S. Securities and Exchange Commission, court records showed. As part of the plea, Jacoby and prosecutors agreed that an appropriate sentence under federal guidelines would be four to 10 months in prison and a fine of up to $5 million.

Osiris Therapeutics Sees Stock Bounce Up On Restatement, Omeros Readies for Presentations of its OMR-721 Candidate Drug
Posted on Wednesday March 29, 2017

NEW YORK, NY / ACCESSWIRE / March 29, 2017 / Stocks of both companies rose on future-oriented news for investors. While FDA clinical trials continue, both companies are getting positive news coverage from ...

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.